Merck (MRK) Revenue & Revenue Breakdown
Merck Revenue Highlights
Latest Revenue (Y)
$60.12B
Latest Revenue (Q)
$16.11B
Main Segment (Y)
Pharmaceutical segment
Main Geography (Y)
UNITED STATES
Merck Revenue by Period
Merck Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $60.12B | 1.40% |
| 2022-12-31 | $59.28B | 21.72% |
| 2021-12-31 | $48.70B | 1.48% |
| 2020-12-31 | $47.99B | 2.46% |
| 2019-12-31 | $46.84B | 10.75% |
| 2018-12-31 | $42.29B | 5.41% |
| 2017-12-31 | $40.12B | 0.79% |
| 2016-12-31 | $39.81B | 0.78% |
| 2015-12-31 | $39.50B | -6.48% |
| 2014-12-31 | $42.24B | -4.08% |
| 2013-12-31 | $44.03B | -6.84% |
| 2012-12-31 | $47.27B | -1.62% |
| 2011-12-31 | $48.05B | 4.48% |
| 2010-12-31 | $45.99B | 67.66% |
| 2009-12-31 | $27.43B | 15.00% |
| 2008-12-31 | $23.85B | -1.44% |
| 2007-12-31 | $24.20B | 6.90% |
| 2006-12-31 | $22.64B | 2.84% |
| 2005-12-31 | $22.01B | -4.04% |
| 2004-12-31 | $22.94B | 2.01% |
| 2003-12-31 | $22.49B | -56.58% |
| 2002-12-31 | $51.79B | 8.54% |
| 2001-12-31 | $47.72B | 18.22% |
| 2000-12-31 | $40.36B | 23.38% |
| 1999-12-31 | $32.71B | 21.62% |
| 1998-12-31 | $26.90B | 13.80% |
| 1997-12-31 | $23.64B | 19.21% |
| 1996-12-31 | $19.83B | 18.87% |
| 1995-12-31 | $16.68B | 11.43% |
| 1994-12-31 | $14.97B | 42.59% |
| 1993-12-31 | $10.50B | - |
Merck generated $60.12B in revenue during NA 2023, up 1.40% compared to the previous quarter, and up 142.14% compared to the same period a year ago.
Merck Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $16.11B | 2.14% |
| 2024-03-31 | $15.78B | 7.83% |
| 2023-12-31 | $14.63B | -8.34% |
| 2023-09-30 | $15.96B | 6.17% |
| 2023-06-30 | $15.04B | 3.78% |
| 2023-03-31 | $14.49B | 4.75% |
| 2022-12-31 | $13.83B | -7.55% |
| 2022-09-30 | $14.96B | 2.51% |
| 2022-06-30 | $14.59B | -8.23% |
| 2022-03-31 | $15.90B | 17.60% |
| 2021-12-31 | $13.52B | 2.79% |
| 2021-09-30 | $13.15B | 15.37% |
| 2021-06-30 | $11.40B | 7.29% |
| 2021-03-31 | $10.63B | -15.09% |
| 2020-12-31 | $12.52B | 14.51% |
| 2020-09-30 | $10.93B | 16.85% |
| 2020-06-30 | $9.35B | -22.43% |
| 2020-03-31 | $12.06B | 1.59% |
| 2019-12-31 | $11.87B | -4.27% |
| 2019-09-30 | $12.40B | 5.42% |
| 2019-06-30 | $11.76B | 8.73% |
| 2019-03-31 | $10.82B | -1.65% |
| 2018-12-31 | $11.00B | 1.89% |
| 2018-09-30 | $10.79B | 3.14% |
| 2018-06-30 | $10.46B | 4.26% |
| 2018-03-31 | $10.04B | -3.80% |
| 2017-12-31 | $10.43B | 1.05% |
| 2017-09-30 | $10.32B | 3.98% |
| 2017-06-30 | $9.93B | 5.26% |
| 2017-03-31 | $9.43B | -6.73% |
| 2016-12-31 | $10.12B | -4.00% |
| 2016-09-30 | $10.54B | 7.03% |
| 2016-06-30 | $9.84B | 5.71% |
| 2016-03-31 | $9.31B | -8.84% |
| 2015-12-31 | $10.21B | 1.41% |
| 2015-09-30 | $10.07B | 2.94% |
| 2015-06-30 | $9.79B | 3.82% |
| 2015-03-31 | $9.43B | -10.08% |
| 2014-12-31 | $10.48B | -0.71% |
| 2014-09-30 | $10.56B | -3.45% |
| 2014-06-30 | $10.93B | 6.53% |
| 2014-03-31 | $10.26B | -9.33% |
| 2013-12-31 | $11.32B | 2.61% |
| 2013-09-30 | $11.03B | 0.20% |
| 2013-06-30 | $11.01B | 3.18% |
| 2013-03-31 | $10.67B | -9.08% |
| 2012-12-31 | $11.74B | 2.17% |
| 2012-09-30 | $11.49B | -6.69% |
| 2012-06-30 | $12.31B | 4.94% |
| 2012-03-31 | $11.73B | -4.58% |
| 2011-12-31 | $12.29B | 2.26% |
| 2011-09-30 | $12.02B | -1.06% |
| 2011-06-30 | $12.15B | 4.93% |
| 2011-03-31 | $11.58B | -4.25% |
| 2010-12-31 | $12.09B | 8.71% |
| 2010-09-30 | $11.13B | -1.95% |
| 2010-06-30 | $11.35B | -0.66% |
| 2010-03-31 | $11.42B | 13.16% |
| 2009-12-31 | $10.09B | 66.84% |
| 2009-09-30 | $6.05B | 2.54% |
| 2009-06-30 | $5.90B | 9.56% |
| 2009-03-31 | $5.39B | -10.73% |
| 2008-12-31 | $6.03B | 1.49% |
| 2008-09-30 | $5.94B | -1.78% |
| 2008-06-30 | $6.05B | 3.95% |
| 2008-03-31 | $5.82B | -6.74% |
| 2007-12-31 | $6.24B | - |
Merck generated $16.11B in revenue during Q2 2024, up 2.14% compared to the previous quarter, and up 111.22% compared to the same period a year ago.
Merck Revenue Breakdown
Merck Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Pharmaceutical segment | $52.01B | $42.75B | $43.02B | $41.75B | $37.69B |
| Other Segments | - | - | $23.00M | $175.00M | $250.00M |
| Animal Health segment | $5.55B | $5.57B | $4.70B | $4.39B | $4.21B |
Merck's latest annual revenue breakdown by segment (product or service), as of Dec 22: Pharmaceutical segment (90.36%), and Animal Health segment (9.64%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Health segment | $1.48B | $1.51B | $1.40B | $1.46B | $1.49B | $1.23B | $1.37B | $1.47B | $1.48B | $1.26B | $1.42B | $1.47B | $1.42B | $1.17B | $1.22B | $1.10B | $1.21B | $1.12B | $1.12B | $1.12B |
| Pharmaceutical segment | $14.41B | $14.01B | $14.26B | $13.46B | $12.72B | $12.18B | $12.96B | $12.76B | $14.11B | $12.04B | $11.50B | $9.98B | $10.68B | $11.37B | $11.32B | $9.68B | $10.65B | $10.53B | $11.10B | $10.46B |
| Other Segments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $23.00M | $42.00M | $46.00M | $48.00M | - |
Merck's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Pharmaceutical segment (90.67%), and Animal Health segment (9.33%).
Merck Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| UNITED STATES | $27.21B | $22.43B | $21.03B | $20.32B | $18.21B |
| Other Countries | $2.57B | $1.22B | $1.23B | $1.61B | $1.15B |
| Latin America | $2.58B | $2.21B | $2.27B | $2.47B | $2.42B |
| JAPAN | $3.63B | $2.73B | $3.38B | $3.58B | $3.21B |
| EMEA | $14.49B | $13.34B | $13.60B | $12.71B | $12.21B |
| CHINA | $5.19B | $4.38B | $3.62B | $3.21B | $2.18B |
| Asia Pacific | $12.43B | $2.41B | $2.86B | $2.94B | $2.91B |
Merck's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (39.95%), EMEA (21.28%), Asia Pacific (18.26%), CHINA (7.62%), JAPAN (5.33%), Latin America (3.79%), and Other Countries (3.77%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | $3.52B | $3.56B | $3.33B | $3.35B | $3.30B | $3.27B | $3.29B | $3.58B | $4.36B | $3.43B | $3.34B | $3.33B | $3.73B | $3.54B | $3.45B | $3.07B | $3.53B | $3.25B | $3.19B | $3.16B |
| Asia Pacific | $3.25B | $3.32B | $781.00M | $848.00M | $846.00M | $822.00M | $854.00M | $1.01B | $930.00M | $625.00M | $613.00M | $594.00M | $751.00M | $735.00M | $735.00M | $666.00M | $728.00M | $726.00M | $756.00M | $716.00M |
| UNITED STATES | $7.88B | $7.48B | $7.71B | $7.02B | $6.66B | $6.28B | $7.32B | $6.24B | $7.34B | $6.26B | $6.28B | $5.10B | $5.14B | $5.63B | $5.63B | $4.63B | $5.14B | $5.14B | $5.53B | $5.14B |
| Latin America | $858.00M | $796.00M | $895.00M | $742.00M | $661.00M | $649.00M | $684.00M | $642.00M | $607.00M | $575.00M | $599.00M | $532.00M | $569.00M | $604.00M | $604.00M | $510.00M | $556.00M | $580.00M | $671.00M | $658.00M |
| CHINA | - | $1.77B | $1.69B | $1.91B | $1.72B | $1.23B | $1.44B | $1.37B | $1.14B | $1.37B | $1.31B | $975.00M | $927.00M | $909.00M | $1.02B | $834.00M | $864.00M | $784.00M | $914.00M | $763.00M |
| Other Countries | - | $621.00M | $469.00M | $491.00M | $545.00M | $728.00M | $698.00M | $637.00M | $534.00M | $462.00M | $379.00M | $207.00M | $238.00M | $225.00M | $289.00M | $290.00M | $427.00M | $437.00M | $423.00M | $395.00M |
| JAPAN | - | $821.00M | $1.08B | $675.00M | $758.00M | $853.00M | $673.00M | $1.11B | $989.00M | $797.00M | $638.00M | $661.00M | $730.00M | $870.00M | $828.00M | $867.00M | $811.00M | $944.00M | $919.00M | $921.00M |
Merck's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (50.81%), EMEA (22.68%), Asia Pacific (20.97%), and Latin America (5.54%).
Merck Peer Comparison by Revenue
MRK Revenue FAQ
What is Merck’s yearly revenue?
Merck's yearly revenue for 2023 was $60.12B, representing an increase of 1.40% compared to 2022. The company's yearly revenue for 2022 was $59.28B, representing an increase of 21.72% compared to 2021. MRK's yearly revenue for 2021 was $48.7B, representing an increase of 1.48% compared to 2020.
What is Merck’s quarterly revenue?
Merck's quarterly revenue for Q2 2024 was $16.11B, a 2.14% increase from the previous quarter (Q1 2024), and a 7.16% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $15.78B, a 7.83% increase from the previous quarter (Q4 2023), and a 8.89% increase year-over-year (Q1 2023). MRK's quarterly revenue for Q4 2023 was $14.63B, a -8.34% decrease from the previous quarter (Q3 2023), and a 5.78% increase year-over-year (Q4 2022).
What is Merck’s revenue growth rate?
Merck's revenue growth rate for the last 3 years (2021-2023) was 23.43%, and for the last 5 years (2019-2023) was 28.34%.
What are Merck’s revenue streams?
Merck's revenue streams in c 22 are Pharmaceutical segment, and Animal Health segment. Pharmaceutical segment generated $52B in revenue, accounting 90.36% of the company's total revenue, up 21.64% year-over-year. Animal Health segment generated $5.55B in revenue, accounting 9.64% of the company's total revenue, down -0.32% year-over-year.
What is Merck’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Merck was Pharmaceutical segment. This segment made a revenue of $52B, representing 90.36% of the company's total revenue.